nan
Bioprocessing Monitoring Market Forecast Highlighting Growth From $3.27 Billion To $3.98 Billion
The industrial bioprocessing market size has witnessed strong growth in recent years. This market is anticipated to expand from $18.95 billion in 2025 to $20.61 billion in 2026, achieving a compound annual growth rate (CAGR) of 8.7%. Historically, this growth has been driven by several factors, including increased demand in pharmaceutical manufacturing, the expansion of industrial enzyme production, the greater adoption of fermentation-based processes, escalating investments in biotechnology research facilities, and the establishment of large-scale biomanufacturing infrastructure.
The industrial bioprocessing market is projected to experience substantial expansion in the coming years. Its valuation is anticipated to reach $29.05 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.0%. This growth trajectory during the forecast period is propelled by several factors, including the increasing need for bio-based chemicals and fuels, the expansion of precision medicine and the production of biologics, a heightened emphasis on cost-effective biomanufacturing methods, the integration of advanced cell culture technologies, and a rising requirement for sustainable industrial production options. Key developments expected during this timeframe encompass the wider acceptance of single-use bioprocessing systems to mitigate contamination risks, an escalating call for highly efficient downstream purification methods, the enlargement of large-scale fermentation capabilities within industrial manufacturing, a developing inclination towards modular and adaptable bioreactor configurations, and an intensified commitment to regulatory-compliant bioproduction procedures to guarantee product uniformity.
Download A Free Sample Report For Comprehensive Market Insights:
Industrial Bioprocessing Market Growth Factors Supporting Long-Term Expansion
The increasing demand for biologics and biopharmaceuticals is projected to drive the expansion of the industrial bioprocessing market moving forward. Biologics and biopharmaceuticals are complex medications manufactured using living cells or organisms to target and manage diverse medical conditions through biological mechanisms. The rise in biologics and biopharmaceuticals is attributable to the growing prevalence of chronic diseases, as these advanced therapies provide highly focused and effective treatment options with improved clinical outcomes compared to conventional drugs. Industrial bioprocessing aids biologics and biopharmaceuticals by enabling the large-scale cultivation of cells and microorganisms necessary for producing complex biological drugs efficiently, consistently, and with high purity via controlled fermentation and downstream processing techniques. For instance, in January 2023, according to Cardinal Health Inc., a US-based healthcare company, as of January 2022, the US had 33 biosimilar products approved by the FDA, with 21 available on the market. By 2023, FDA-approved biosimilars had increased to 40, with 25 commercially available. Therefore, the escalating demand for biologics and biopharmaceuticals is propelling the growth of the industrial bioprocessing market.
Bioprocessing Monitoring Market Categorization By Product Type And Application
The industrial bioprocessing market covered in this report is segmented –
1) By Type: Upstream Processing; Downstream Processing; Process Analytical Technologies; Bioprocess Consumables And Accessories
2) By Technology: Fermentation; Biocatalysis; Cell Culture; Other Technologies
3) By Application: Biopharmaceutical Production; Industrial Enzymes; Biofuels; Food And Beverage Processing; Wastewater Treatment; Agricultural Biotechnology
4) By End User: Industrial; Commercial; Residential
Subsegments:
1) By Upstream Processing: Cell Culture Media; Buffer Solutions; Bioreactors; Fermentation Systems; Filtration Systems; Cell Separation Equipment; Sensors And Monitoring Devices
2) By Downstream Processing: Chromatography Systems; Filtration Technologies; Centrifugation Equipment; Drying Equipment; Purification Resins; Separation Membranes; Concentration Systems
3) By Process Analytical Technologies: Spectroscopy Systems; Chromatography Analyzers; Particle Size Analyzers; Biomass Monitoring Systems; Gas Analysis Systems; Ph Measurement Systems; Data Management Software
4) By Bioprocess Consumables And Accessories: Single Use Bags; Filters; Tubing Assemblies; Culture Media; Reagents; Sampling Devices; Connectors And Fittings
Strategic Partnerships Enhance Upstream Process Intensification And Biomanufacturing Efficiency In Industrial Bioprocessing
Major companies operating in the industrial bioprocessing market are focusing on developing strategic partnerships to enhance upstream processing efficiency, accelerate process intensification, and improve biomanufacturing productivity. Strategic partnerships refer to collaborative agreements between companies to combine technologies, expertise, and resources to accelerate innovation, improve operational efficiency, and expand capabilities in industrial bioprocessing. For instance, in August 2023, Sartorius AG, a Germany-based life sciences company, collaborated with Repligen Corporation, a US-based bioprocessing technology company, to launch an integrated system combining the Biostat STR bioreactor with XCell ATF technology for upstream process intensification. The solution is designed to enable high-density cell culture and intensified perfusion processes, improving productivity and efficiency in industrial bioprocessing applications used for the production of biologics such as monoclonal antibodies and other therapeutic proteins.
Industrial Bioprocessing Market Key Players: Which Companies Shape Industry Competition?
Major companies operating in the industrial bioprocessing market are Thermo Fisher Scientific; Danaher Corporation; Merck KGaA; Sartorius Aktiengesellschaft; Avantor Inc.; Corning Inc.; GEA Group Aktiengesellschaft; Repligen Corporation; Entegris Inc.; Eppendorf SE; Parker Hannifin; Hamilton Company; ZETA Holding GmbH; Glatt Ingenieurtechnik GmbH; Rentschler Biopharma SE; Meissner Filtration Products Inc.; Shanghai Tofflon Science and Technology Co. Ltd.; ABEC Inc.; Codexis Inc.; PBS Biotech Inc.; Broadley-James Corporation; INFORS HT; CerCell ApS; Wacker Biotech GmbH; BPC Instruments AB; OmniBRx Biotechnologies Pvt. Ltd.; Bailun Biotechnology Co. Ltd.; Adolf Kühner AG; Fermenter Technologies Pty Ltd
Access The Complete Industrial Bioprocessing Market Report:
Industrial Bioprocessing Market Regional Outlook: Where Are The Largest Opportunities Located?
North America was the largest region in the industrial bioprocessing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the industrial bioprocessing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.